Aims: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. Methods: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NISH) for HPV types 6, 11, 16, 18, 31, 33, and 35 NISH was performed using digoxigenin labelled genomic probes for HPV 6, 11, 16, 18, 31, 33, and 35 as previously described for HPV detection in CIN and squamous cell cancer (SCC).'6"' Biopsy specimens (of CIN or SCC) known to contain HPV16 and 18 were analysed in parallel with each batch of cases as positive controls.
The association between HPV and genital intraepithelial neoplasia and invasive malignancy has resulted in over 20 genotypes being identified in the genital tract within the last decade (for review see de Villiers) .' The majority of these HPV types were isolated from neoplastic squamous epithelium. More recently there has been increasing interest in the association between HPV and glandular neoplasia of the cervix. In 1988 it was shown that HPV DNA was found as frequently in adenocarcinoma and adenosquamous cancer as in squamous cell cancer of the cervix.2 It was also demonstrated that HPV18 was the predominant HPV type in adenocarcinoma. Although the latter association has been confirmed in other studies,3-" two reports from the UK failed to show a significant association.4 15 HPV DNA is present in three morphologically distinct forms in the nuclei of cervical intraepithelial neoplasia (CIN) and cervical squamous cell cancer (SCC) by nonisotopic in situ hybridisation (NISH were analysed in parallel with each batch of cases as positive controls.
Results

NISH GENOTYPING OF HPV
A total of 20 adenocarcinomas (53%) from HPV integration in cervical adenocarcinoma 
